World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
64
Citations
24149
World Ranking
3204
National Ranking
276

Overview

Oliver Peters is affiliated with the German Center for Neurodegenerative Diseases in Germany. Their research primarily encompasses the fields of Medicine and Neuroscience, with significant contributions to Psychiatry and Mental Health, Physiology, Cognitive Neuroscience, Neurology, and Radiology, Nuclear Medicine and Imaging. Their work focuses notably on dementia, cognitive impairment, and Alzheimer's disease, alongside broader neurological disease mechanisms and treatments.

Their main topics of study include:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's Disease Research and Treatments
  • Functional Brain Connectivity Studies
  • Advanced Neuroimaging Techniques and Applications
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neurological Disease Mechanisms and Treatments
  • Parkinson's Disease Mechanisms and Treatments

Oliver Peters has published extensively, with frequent appearances in venues such as Alzheimer s & Dementia, bioRxiv (Cold Spring Harbor Laboratory), Journal of Alzheimer s Disease, Alzheimer s Research & Therapy, and Brain.

Recent publications include:

  • "Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease" (2020, Molecular Systems Biology)
  • "Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease" (2022, JAMA Neurology)
  • "Anti-amyloid antibody therapies in Alzheimer's disease" (2023, Brain)
  • "Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age" (2021, Neurology)
  • "Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS" (2024, Nature Medicine)

Frequent co-authors collaborating with Oliver Peters include Anja Schneider, Jens Wiltfang, Josef Priller, Annika Spottke, and Emrah Düzel. These collaborations contribute to a substantial number of joint publications.

Best Publications

  • Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

    Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration

    Sabrina M Lehmann;Christina Krüger;Boyoun Park;Katja Derkow

  • Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

    Lesley Jones;Peter A. Holmans;Marian L. Hamshere;Denise Harold

  • Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

    Henryk Barthel;Hermann-Josef Gertz;Stefan Dresel;Oliver Peters

  • Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline

    Johannes vom Berg;Stefan Prokop;Kelly R Miller;Juliane Obst

  • Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.

    Stephanie J B Vos;Frans Verhey;Lutz Frölich;Johannes Kornhuber

  • Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat

    Oliver Peters;Tobias Back;Ute Lindauer;Christina Busch

  • Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Itziar de Rojas;Itziar de Rojas;Sonia Moreno-Grau;Sonia Moreno-Grau;Niccolo Tesi;Benjamin Grenier-Boley

  • Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

    Jens Wiltfang;Hermann Esselmann;Mirko Bibl;Michael Hüll

  • Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease

    Jakob M Bader;Philipp E Geyer;Philipp E Geyer;Johannes B Müller;Maximilian T Strauss

  • Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).

    Frank Jessen;Frank Jessen;Annika Spottke;Annika Spottke;Henning Boecker;Henning Boecker;Frederic Brosseron

  • Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain.

    Sebastian Jander;Michael Schroeter;Oliver Peters;Otto W. Witte

  • Different Mechanisms Promote Astrocyte Ca2+ Waves and Spreading Depression in the Mouse Neocortex

    Oliver Peters;Carola G. Schipke;Yoshinori Hashimoto;Helmut Kettenmann

  • Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease

    M. Wagner;S. Wolf;F.M. Reischies;M. Daerr

  • Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

    P Lewczuk;H Kamrowski-Kruck;O Peters;I Heuser

  • Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type

    Julius Popp;Julius Popp;Steffen Wolfsgruber;Steffen Wolfsgruber;Isabella Heuser;Oliver Peters

  • Activity-dependent ATP-waves in the Mouse Neocortex are Independent from Astrocytic Calcium Waves

    Brigitte Haas;Carola G. Schipke;Oliver Peters;Goran Söhl

  • Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

    Willemijn J Jansen;Rik Ossenkoppele;Betty M Tijms;Anne M Fagan

  • Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age.

    Tommaso Ballarini;Debora Melo van Lent;Debora Melo van Lent;Julia Brunner;Alina Schröder

  • Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

    P. Lewczuk;J. Kornhuber;E. Vanmechelen;O. Peters

  • Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.

    Piotr Lewczuk;Johannes Kornhuber;Hugo Vanderstichele;Eugeen Vanmechelen

Frequent Co-Authors

Christoph Laske
Christoph Laske University of Tübingen
Katharina Buerger
Katharina Buerger Ludwig-Maximilians-Universität München
Emrah Düzel
Emrah Düzel German Center for Neurodegenerative Diseases
Michael T. Heneka
Michael T. Heneka University Hospital Bonn
Stefan J. Teipel
Stefan J. Teipel German Center for Neurodegenerative Diseases
Robert Perneczky
Robert Perneczky Ludwig-Maximilians-Universität München
Wiesje M. van der Flier
Wiesje M. van der Flier Vrije Universiteit Amsterdam
Peter J. Nestor
Peter J. Nestor University of Queensland
Johannes Pantel
Johannes Pantel Goethe University Frankfurt
Martin Dichgans
Martin Dichgans Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Oliver Peters

Trending Scientists